15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Prothena Corporation plc, 3 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $12.00 to $36.00 (about 3.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $24.50 sits 157% above the current $9.55. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.74 next quarter toward $-1.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy375%
Hold125%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Prothena Corporation plc.
As of Sep, 3 of 4 firms rate PRTA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PRTA EPS & revenue forecast
EPS · NEXT QUARTER
$0.74
Range $0.74 – $0.74 · 1 analysts · -262% YoY
Next period, 1 analysts expect Prothena Corporation plc to earn $0.74 a share (range $0.74 – $0.74), versus $-0.46 a year earlier. Full-year consensus is $0.65, growing to $-1.52 the year after.
REVENUE · NEXT QUARTER
$21.5M
Range $0 – $55.0M · 1 analysts · +102282% YoY
Revenue is expected to reach $21.5M (range $0 – $55.0M), +102281.8% year-over-year. Full-year consensus is $83.2M, rising to $24.4M next year.
Top analysts covering Prothena Corporation plc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PRTA.
#1
Jason Butler
JMP Securities · Rank #31
Buy
$20.00+109.4% to target
Overall win rate
53%
+ Follow
#2
Andrew Fein
HC Wainwright & Co. · Rank #55
Buy
$30.00+214.1% to target
Overall win rate
46%
+ Follow
#3
Yasmeen Rahimi
Piper Sandler · Rank #188
Buy
$36.00+277.0% to target
Overall win rate
33%
+ Follow
#4
TA
Tazeen Ahmad
B of A Securities · Rank #317
Sell
$8.00-16.2% to target
Overall win rate
47%
+ Follow
#5
Jay Olson
Oppenheimer · Rank #360
Hold
No targeton PRTA
Overall win rate
33%
+ Follow
PRTA stock forecast FAQ
What is PRTA's average 12-month price target?+
The 4 analysts with a live target average $24.50 for Prothena Corporation plc over the next 12 months, ranging from a $36.00 high to a $12.00 low.
Is PRTA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 3 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PRTA?+
The Street-high target is $36.00 (Piper Sandler), and the Street-low is $12.00 (RBC Capital). The average of all 4 active targets is $24.50.
How many Wall Street analysts cover PRTA?+
4 analysts have an active rating on Prothena Corporation plc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering PRTA?+
Among analysts who currently cover PRTA, Jason Butler of JMP Securities has the strongest overall Quantellect track record (Rank #31). Their current call is Buy with a $20.00 target.
What is Prothena Corporation plc's projected EPS for next quarter?+
The consensus estimate is $0.74 per share (range $0.74 – $0.74) across 1 analysts. Full-year EPS is projected at $0.65, rising to $-1.52 the following year.
How much revenue is Prothena Corporation plc expected to report next quarter?+
Consensus revenue is $21.5M (range $0 – $55.0M). Full-year revenue is projected at $83.2M, growing to $24.4M next year.
Have analysts been upgrading or downgrading PRTA lately?+
As of Sep, 3 of 4 firms rate PRTA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PRTA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
